Yongtao Su
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Research Subjects
Yongtao Su has a total of 28 co-authors. Here are the top co-authors by number of shared publications:
Chunlei Wang
Burn and Wound Repair Center, Department of Plastic and Aesthetic Surgery, PKU Healthcare Luzhong Hospital, Zibo, 255400, Shandong province, China
2 shared publicationsQianqian Luo
The First Clinical Medical College, Shandong University of Traditional Chinese Medicine, Jinan, 250000, Shandong province, China
2 shared publicationsYing Sui
Institute of Tissue Regeneration and Wound Repair, Institute of Pharmacy, Shandong University of Traditional Chinese Medicine, Jinan, 250355, China
2 shared publicationsChengen Liu
The Second Clinical Medical College Binzhou Medical University 264003 Yantai China
1 shared publicationChunli Huang
School of Clinical Medicine, Shandong Second Medical University, Weifang 261000, Shandong Province, China.
1 shared publicationChunxiao Hu
Shandong Univ, Qilu Hosp, Dept Emergency Neurosurg, Intens Care Unit, Jinan, Shandong, Peoples R China
1 shared publication
Latest Publications
- Open Access
- 29 September 2026
- Published by Frontiers Media SA in Frontiers in Surgery
- Vol. 13, 1975183
A large iliopsoas abscess due to migration of ureteral stent: a case report
Background: Iliopsoas abscess (IPA) is a rare but potentially life-threatening condition. Due to its nonspecific clinical presentation and low incidence, IPA often leads to diagnostic delays and suboptimal initial management. Secondary IPA originating from urinary tract complications is extremely rare, and IPA induced by ureteral stent migration appears to be exceptionally uncommon. Fungal IPA caused by Candida tropicalis is also a scarcely reported clinical entity, especially in immunocompromised patients with long-term rheumatoid arthritis (RA). Case presentation: We report a 63-year-old woman with a history of rheumatoid arthritis (RA) and prior colon cancer surgery that involved partial ureteral resection and ureteral stent implantation 6 months ago. The patient later developed IPA, which was successfully managed with dual ultrasound-guided percutaneous drainage, ureteral stent exchange, and systemic antimicrobial therapy. Cultures of the drained abscess and urine both yielded C. tropicalis ; the drainage-fluid creatinine (5,334 μmol/L) was consistent with urine, suggesting that the IPA likely originated from infected urine leaking from the ureteral anastomosis due to migration of the ureteral stent. The patient was eventually discharged without further complications. Conclusion: Ultrasound-guided percutaneous drainage is a safe and effective treatment modality for IPA. This case highlights that ureteral stent migration, though typically managed uneventfully, may precipitate severe septic sequelae including IPA, particularly in immunocompromised patients.
- 29 September 2026
- Published by Frontiers Media SA in Frontiers in Surgery
- Vol. 13, 1975183
Open AccessA large iliopsoas abscess due to migration of ureteral stent: a case report
Background: Iliopsoas abscess (IPA) is a rare but potentially life-threatening condition. Due to its nonspecific clinical presentation and low incidence, IPA often leads to diagnostic delays and suboptimal initial management. Secondary IPA originating from urinary tract complications is extremely rare, and IPA induced by ureteral stent migration appears to be exceptionally uncommon. Fungal IPA caused by Candida tropicalis is also a scarcely reported clinical entity, especially in immunocompromised patients with long-term rheumatoid arthritis (RA). Case presentation: We report a 63-year-old woman with a history of rheumatoid arthritis (RA) and prior colon cancer surgery that involved partial ureteral resection and ureteral stent implantation 6 months ago. The patient later developed IPA, which was successfully managed with dual ultrasound-guided percutaneous drainage, ureteral stent exchange, and systemic antimicrobial therapy. Cultures of the drained abscess and urine both yielded C. tropicalis ; the drainage-fluid creatinine (5,334 μmol/L) was consistent with urine, suggesting that the IPA likely originated from infected urine leaking from the ureteral anastomosis due to migration of the ureteral stent. The patient was eventually discharged without further complications. Conclusion: Ultrasound-guided percutaneous drainage is a safe and effective treatment modality for IPA. This case highlights that ureteral stent migration, though typically managed uneventfully, may precipitate severe septic sequelae including IPA, particularly in immunocompromised patients.
- 7 July 2026
- Published by Springer Nature in Functional & Integrative Genomics
- Vol. 26 (1)
Integrated multi-omics analysis reveals key molecular mechanisms underlying fibroproliferation and immune dysregulation in keloids
Keloids are benign fibroproliferative skin lesions characterized by excessive collagen deposition and growth beyond the original wound margins. However, the cellular heterogeneity and molecular mechanisms underlying keloid pathogenesis remain incompletely understood. Publicly available single-cell RNA sequencing (scRNA-seq) data from keloid tissues of eight patients were obtained from the NCBI Gene Expression Omnibus (GEO) database. High-dimensional weighted gene co-expression network analysis (hdWGCNA) was performed to identify disease-associated gene modules. Mendelian randomization (MR) analysis was performed using summary statistics from BioBank Japan to evaluate potential associations between gene expression and keloid susceptibility. ATAC-seq data were used to assess chromatin accessibility, and SCENIC analysis was performed to infer transcription factor regulon activity. Correlation analysis was then used to assess potential associations between candidate transcription factors and target genes. We analyzed 73,790 cells and identified nine major cell types. Fibroblasts showed substantial heterogeneity and were further classified into 6 subpopulations. Trajectory analysis suggested a differentiation continuum among disease-associated fibroblasts, and cell-cell communication analysis indicated that MSC-like fibroblasts may function as a signaling hub. hdWGCNA identified a turquoise co-expression module significantly enriched in MSC-like fibroblasts. MR analysis highlighted CLEC2B, MGST3, and SFRP2 as candidate genes potentially associated with keloids, and qRT-PCR validated their differential mRNA expression between normal dermal and keloid fibroblasts. ATAC-seq analysis identified 4,607 differentially accessible chromatin peaks. Integrated motif enrichment and SCENIC analyses identified CREB3L1 and ZEB1 as candidate transcription factors. Correlation analysis further suggested potential regulatory relationships between these transcription factors and the candidate genes. This study provides an integrative multi-omics characterization of cellular heterogeneity in keloids. It identifies CLEC2B, MGST3, and SFRP2 as key candidate genes, as well as CREB3L1 and ZEB1 as candidate transcription factors potentially involved in keloid pathogenesis. These findings improve our understanding of keloid biology and may provide a basis for future therapeutic research.
- 7 July 2026
- Published by Springer Nature in Functional & Integrative Genomics
- Vol. 26 (1)
Integrated multi-omics analysis reveals key molecular mechanisms underlying fibroproliferation and immune dysregulation in keloids
Keloids are benign fibroproliferative skin lesions characterized by excessive collagen deposition and growth beyond the original wound margins. However, the cellular heterogeneity and molecular mechanisms underlying keloid pathogenesis remain incompletely understood. Publicly available single-cell RNA sequencing (scRNA-seq) data from keloid tissues of eight patients were obtained from the NCBI Gene Expression Omnibus (GEO) database. High-dimensional weighted gene co-expression network analysis (hdWGCNA) was performed to identify disease-associated gene modules. Mendelian randomization (MR) analysis was performed using summary statistics from BioBank Japan to evaluate potential associations between gene expression and keloid susceptibility. ATAC-seq data were used to assess chromatin accessibility, and SCENIC analysis was performed to infer transcription factor regulon activity. Correlation analysis was then used to assess potential associations between candidate transcription factors and target genes. We analyzed 73,790 cells and identified nine major cell types. Fibroblasts showed substantial heterogeneity and were further classified into 6 subpopulations. Trajectory analysis suggested a differentiation continuum among disease-associated fibroblasts, and cell-cell communication analysis indicated that MSC-like fibroblasts may function as a signaling hub. hdWGCNA identified a turquoise co-expression module significantly enriched in MSC-like fibroblasts. MR analysis highlighted CLEC2B, MGST3, and SFRP2 as candidate genes potentially associated with keloids, and qRT-PCR validated their differential mRNA expression between normal dermal and keloid fibroblasts. ATAC-seq analysis identified 4,607 differentially accessible chromatin peaks. Integrated motif enrichment and SCENIC analyses identified CREB3L1 and ZEB1 as candidate transcription factors. Correlation analysis further suggested potential regulatory relationships between these transcription factors and the candidate genes. This study provides an integrative multi-omics characterization of cellular heterogeneity in keloids. It identifies CLEC2B, MGST3, and SFRP2 as key candidate genes, as well as CREB3L1 and ZEB1 as candidate transcription factors potentially involved in keloid pathogenesis. These findings improve our understanding of keloid biology and may provide a basis for future therapeutic research.
- Open Access
- 1 January 2026
- Published by Wiley in BioMed Research International
- Vol. 2026 (1) , e6652338
Exosomes From Adipose‐Derived Mesenchymal Stem Cells: A New Prospective Therapy of Diabetic Foot Ulcer
Diabetic foot ulcer (DFU) is one of the most severe complications of diabetes, characterized by high rates of morbidity, disability, and mortality. Current treatment modalities for DFU primarily include surgical debridement, negative‐pressure wound therapy, and anti‐infection measures. However, these approaches are limited by prolonged treatment duration, high costs, and suboptimal therapeutic outcomes. Adipose‐derived mesenchymal stem cells (ADMSCs) have garnered significant attention in wound repair and tissue regeneration due to their ability to secrete a variety of cytokines involved in the healing process. Exosomes, as key mediators of the paracrine effects underlying the therapeutic benefits of ADMSCs, are emerging as promising agents for wound repair. As a novel therapeutic strategy, exosomes have been increasingly investigated for the treatment of DFU. In this review, we summarize the applications and therapeutic potential of ADMSC‐exosomes in DFU, aiming to provide a valuable reference for its clinical management.
- 1 January 2026
- Published by Wiley in BioMed Research International
- Vol. 2026 (1) , e6652338
Open AccessExosomes From Adipose‐Derived Mesenchymal Stem Cells: A New Prospective Therapy of Diabetic Foot Ulcer
Diabetic foot ulcer (DFU) is one of the most severe complications of diabetes, characterized by high rates of morbidity, disability, and mortality. Current treatment modalities for DFU primarily include surgical debridement, negative‐pressure wound therapy, and anti‐infection measures. However, these approaches are limited by prolonged treatment duration, high costs, and suboptimal therapeutic outcomes. Adipose‐derived mesenchymal stem cells (ADMSCs) have garnered significant attention in wound repair and tissue regeneration due to their ability to secrete a variety of cytokines involved in the healing process. Exosomes, as key mediators of the paracrine effects underlying the therapeutic benefits of ADMSCs, are emerging as promising agents for wound repair. As a novel therapeutic strategy, exosomes have been increasingly investigated for the treatment of DFU. In this review, we summarize the applications and therapeutic potential of ADMSC‐exosomes in DFU, aiming to provide a valuable reference for its clinical management.
- 19 December 2025
- Published by Elsevier in Biochemical and Biophysical Research Communications
- Vol. 797, 153171
Tanshinone IIA accelerates diabetic wound healing via suppression of macrophage NLRP3 inflammasome activity
- 19 December 2025
- Published by Elsevier in Biochemical and Biophysical Research Communications
- Vol. 797, 153171
Tanshinone IIA accelerates diabetic wound healing via suppression of macrophage NLRP3 inflammasome activity
- Open Access
- 18 November 2025
- Published by Springer Nature in Journal of Ovarian Research
- Vol. 18 (1) , 269
hUCMSCs restore ovarian function via angiopoietin 1/2 rebalance in POI rats
Background Premature ovarian insufficiency (POI) is often iatrogenic and the therapeutic potential of human umbilical cord derived mesenchymal stem cells (hUCMSCs) remain incompletely defined. This study aimed to evaluate the effects and underlying mechanism of hUCMSCs on ovarian function in a rat model of POI. Methods hUCMSCs were characterized by morphology, flow cytometry, and multi-lineage differentiation assays. POI was induced in rats using cyclophosphamide (CTX), followed by intravenous administration of hUCMSCs. Therapeutic outcomes were assessed through cell homing analysis, ovarian histopathology, and serum hormone measurements. Bioinformatic analysis identified Angiopoietin 1 (Angpt1) as a key angiogenic regulator, which was validated by western blot and qRT-PCR. Rat ovarian microvascular endothelial cells (ROMECs) were isolated and functionally assessed under CTX and hUCMSCs treatment using wound healing, tube formation, and evaluation of the Angpt1 and Angpt2 balance. Results In vivo, hUCMSCs preferentially homed to the ovarian theca layer and restored ovarian function. The Angpt1/ Angpt2 ratio was markedly reduced in POI rats but significantly increased after hUCMSCs treatment, and the ratio positively correlated with CD31 expression. In vitro, CTX impaired ROMECs migration and angiogenic capacity, whereas coculture with hUCMSCs rescued these functions and restored the Angpt1/Angpt2 ratio. Conclusion hUCMSCs ameliorate ovarian dysfunction in POI by modulating the Angpt1/Angpt2 axis, thereby enhancing vascular homeostasis and angiogenesis within the ovarian microenvironment. These findings provided mechanistic insights supporting the clinical translation of hUCMSCs-based therapies for POI.
- 18 November 2025
- Published by Springer Nature in Journal of Ovarian Research
- Vol. 18 (1) , 269
Open AccesshUCMSCs restore ovarian function via angiopoietin 1/2 rebalance in POI rats
Background Premature ovarian insufficiency (POI) is often iatrogenic and the therapeutic potential of human umbilical cord derived mesenchymal stem cells (hUCMSCs) remain incompletely defined. This study aimed to evaluate the effects and underlying mechanism of hUCMSCs on ovarian function in a rat model of POI. Methods hUCMSCs were characterized by morphology, flow cytometry, and multi-lineage differentiation assays. POI was induced in rats using cyclophosphamide (CTX), followed by intravenous administration of hUCMSCs. Therapeutic outcomes were assessed through cell homing analysis, ovarian histopathology, and serum hormone measurements. Bioinformatic analysis identified Angiopoietin 1 (Angpt1) as a key angiogenic regulator, which was validated by western blot and qRT-PCR. Rat ovarian microvascular endothelial cells (ROMECs) were isolated and functionally assessed under CTX and hUCMSCs treatment using wound healing, tube formation, and evaluation of the Angpt1 and Angpt2 balance. Results In vivo, hUCMSCs preferentially homed to the ovarian theca layer and restored ovarian function. The Angpt1/ Angpt2 ratio was markedly reduced in POI rats but significantly increased after hUCMSCs treatment, and the ratio positively correlated with CD31 expression. In vitro, CTX impaired ROMECs migration and angiogenic capacity, whereas coculture with hUCMSCs rescued these functions and restored the Angpt1/Angpt2 ratio. Conclusion hUCMSCs ameliorate ovarian dysfunction in POI by modulating the Angpt1/Angpt2 axis, thereby enhancing vascular homeostasis and angiogenesis within the ovarian microenvironment. These findings provided mechanistic insights supporting the clinical translation of hUCMSCs-based therapies for POI.
- Open Access
- 21 October 2025
- Published by Wolters Kluwer Health in International Journal of Surgery
- Vol. 112 (1) , 71-83
Consensus statement on the clinical application of extracorporeal shock wave therapy for diabetic foot ulcers (2025 Edition)
Diabetic foot ulcers (DFUs) are among the most severe late-stage complications in patients with diabetes. It is characterized by complex pathogenic factors, challenging treatments, and high rates of disability and mortality. Therefore, DFUs have become a major therapeutic challenge for patients with diabetes. In recent years, extracorporeal shock wave therapy (ESWT) has emerged as a novel modality for promoting the healing of both acute and chronic superficial wounds. An increasing number of studies have demonstrated significant clinical efficacy in the treatment of DFUs. Developed by experts from the Wound Repair Committee of the Chinese Medical Doctor Association through an extensive review of high-quality literature, this consensus systematically outlines the indications, contraindications, standardized procedures, key technical points, post-treatment patient management and assessment, and prevention and management of potential complications related to ESWT for DFUs. This consensus aims to provide clinical guidance and a practical reference for physicians in wound repair departments to apply ESWT in the management of diabetic foot ulcers.
- 21 October 2025
- Published by Wolters Kluwer Health in International Journal of Surgery
- Vol. 112 (1) , 71-83
Open AccessConsensus statement on the clinical application of extracorporeal shock wave therapy for diabetic foot ulcers (2025 Edition)
Diabetic foot ulcers (DFUs) are among the most severe late-stage complications in patients with diabetes. It is characterized by complex pathogenic factors, challenging treatments, and high rates of disability and mortality. Therefore, DFUs have become a major therapeutic challenge for patients with diabetes. In recent years, extracorporeal shock wave therapy (ESWT) has emerged as a novel modality for promoting the healing of both acute and chronic superficial wounds. An increasing number of studies have demonstrated significant clinical efficacy in the treatment of DFUs. Developed by experts from the Wound Repair Committee of the Chinese Medical Doctor Association through an extensive review of high-quality literature, this consensus systematically outlines the indications, contraindications, standardized procedures, key technical points, post-treatment patient management and assessment, and prevention and management of potential complications related to ESWT for DFUs. This consensus aims to provide clinical guidance and a practical reference for physicians in wound repair departments to apply ESWT in the management of diabetic foot ulcers.
- Open Access
- 1 September 2025
- Published by China Science Publishing & Media Ltd. in Journal of Zhejiang University (Medical Sciences)
- Vol. 54 (5) , 602-610
Single-cell transcriptomic analysis reveals immune dysregula-tion and macrophage reprogramming in diabetic foot ulcers
To elucidate the mechanisms underlying macrophage-mediated inflammation and tissue injury in diabetic foot ulcers (DFU). Skin tissue samples were collected from patients with diabetic foot ulcers and with non-ulcer diabetic foot (NDFU). A total of 79 272 high-quality cell transcriptomes were obtained using single-cell RNA sequencing. An unbiased clustering approach was employed to identify cell subpopulations. Systematic comparative analyses between the DFU and NDFU groups were conducted, including Gene Ontology (GO) enrichment analysis and screening of differentially expressed genes. Furthermore, cell-cell communication network construction and ligand-receptor interaction analysis were integrated to reveal the mechanisms underlying cellular interactions and signaling regulation in the DFU microenvironment from multiple perspectives. The results revealed a significant expansion of myeloid cells in DFU tissues, alongside a marked reduction in structural cells such as endothelial cells, epithelial cells, and smooth muscle cells. Major cell types underwent functional reprogramming, characterized by immune activation and impaired tissue remodeling. Specifically, macrophages in DFU tissues exhibited a shift toward a pro-inflammatory M1 phenotype, with upregulation of genes associated with inflammation and oxidative stress. Cell communication analysis further demonstrated that M1 macrophages act as both primary signal receivers and influencers in the COMPLEMENT pathway, and as key signal senders and regulators in the SPP1 pathway, actively shaping the inflammatory microenvironment. Key ligand-receptor interactions driving macrophage signaling were identified, including C3-(ITGAM+ITGB2) and SPP1-CD44. This study establishes a comprehensive single-cell atlas of DFU, revealing the role of macrophage-driven cellular networks in chronic inflammation and impaired healing. These findings may offer potential novel therapeutic targets for DFU treatment.
- 1 September 2025
- Published by China Science Publishing & Media Ltd. in Journal of Zhejiang University (Medical Sciences)
- Vol. 54 (5) , 602-610
Open AccessSingle-cell transcriptomic analysis reveals immune dysregula-tion and macrophage reprogramming in diabetic foot ulcers
To elucidate the mechanisms underlying macrophage-mediated inflammation and tissue injury in diabetic foot ulcers (DFU). Skin tissue samples were collected from patients with diabetic foot ulcers and with non-ulcer diabetic foot (NDFU). A total of 79 272 high-quality cell transcriptomes were obtained using single-cell RNA sequencing. An unbiased clustering approach was employed to identify cell subpopulations. Systematic comparative analyses between the DFU and NDFU groups were conducted, including Gene Ontology (GO) enrichment analysis and screening of differentially expressed genes. Furthermore, cell-cell communication network construction and ligand-receptor interaction analysis were integrated to reveal the mechanisms underlying cellular interactions and signaling regulation in the DFU microenvironment from multiple perspectives. The results revealed a significant expansion of myeloid cells in DFU tissues, alongside a marked reduction in structural cells such as endothelial cells, epithelial cells, and smooth muscle cells. Major cell types underwent functional reprogramming, characterized by immune activation and impaired tissue remodeling. Specifically, macrophages in DFU tissues exhibited a shift toward a pro-inflammatory M1 phenotype, with upregulation of genes associated with inflammation and oxidative stress. Cell communication analysis further demonstrated that M1 macrophages act as both primary signal receivers and influencers in the COMPLEMENT pathway, and as key signal senders and regulators in the SPP1 pathway, actively shaping the inflammatory microenvironment. Key ligand-receptor interactions driving macrophage signaling were identified, including C3-(ITGAM+ITGB2) and SPP1-CD44. This study establishes a comprehensive single-cell atlas of DFU, revealing the role of macrophage-driven cellular networks in chronic inflammation and impaired healing. These findings may offer potential novel therapeutic targets for DFU treatment.
- 1 June 2024
- Published by Edizioni Minerva Medica in Minerva Medica
Bioinformatics analysis of the prognostic value of ADH1B gene in diabetic foot ulcer
Article: Bioinformatics analysis of the prognostic value of ADH1B gene in diabetic foot ulcer - Minerva Medica 2024 Jun 05 - Minerva Medica - Journals
- 1 June 2024
- Published by Edizioni Minerva Medica in Minerva Medica
Bioinformatics analysis of the prognostic value of ADH1B gene in diabetic foot ulcer
Article: Bioinformatics analysis of the prognostic value of ADH1B gene in diabetic foot ulcer - Minerva Medica 2024 Jun 05 - Minerva Medica - Journals